Higazi; Abd Al-Roof

Patent Applications and Registrations

Patent applications and USPTO patent grants for Higazi; Abd Al-Roof.The latest application filed is for "peptides derived from plasminogen activator inhibitor-1 and uses thereof".

Company Profile

0.14.10

Higazi; Abd Al-Roof - Mobile Post Shimshon IL
Higazi; Abd Al-Roof - Haverford PA
Higazi; Abd Al-Roof - Jerusalem IL
Higazi; Abd. Al-Roof - Shimshon IL
Higazi; Abd Al-Roof - Bala Cynwyd PA
Higazi; Abd. Al-Roof - D.N. Shimshon IL
Higazi; Abd. Al-Roof - 99761 D.N. Shimshon IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Peptides derived from plasminogen activator inhibitor-1 and uses thereof Grant 8,507,436 - Higazi August 13, 2	2013-08-13
Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots Grant 7,837,997 - Muzykantov , et al. November 23, 2	2010-11-23
Peptides Derived From Plasminogen Activator Inhibitor-1 And Uses Thereof App 20100215636 - Higazi; Abd Al-Roof	2010-08-26
Compositions and methods for modulating muscle cell and tissue contractility Grant 7,425,534 - Cines , et al. September 16, 2	2008-09-16
Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots App 20080050389 - Muzykantov; Vladimir R. ; et al.	2008-02-28
Peptides for regulation of urokinase (uPA) and tissue type (tPA) plasminogen activator and method of optimizing therapeutic efficacy Grant 7,271,143 - Higazi September 18, 2	2007-09-18
Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator Grant 7,247,611 - Cines , et al. July 24, 2	2007-07-24
Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots Grant 7,172,760 - Muzykantov , et al. February 6, 2	2007-02-06
Use of lipid conjugates in the treatment of disease Grant 7,034,006 - Yedgar , et al. April 25, 2	2006-04-25
Peptide for regulation of urokinase plasminogen activator and method of optimizing therapeutic efficacy App 20060069035 - Higazi; Abd. Al-Roof	2006-03-30
Medical uses of scuPA/suPAR complex Grant 6,911,316 - Higazi June 28, 2	2005-06-28
suPAR stimulating activity of tcuPA-mediated fibrinolysis and different uses thereof Grant 6,861,054 - Higazi March 1, 2	2005-03-01
Compositions and methods for modulating muscle cell and tissue contractility Grant 6,833,357 - Cines , et al. December 21, 2	2004-12-21
Use of cross-linked, covalently bound urokinase plasminogen activator (scuPA)-urokinase plasminogen activator receptor (suPAR) complex as a fibrinolytic agent Grant 6,759,042 - Higazi July 6, 2	2004-07-06
Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator Grant 6,750,201 - Cines , et al. June 15, 2	2004-06-15
Peptide for regulation of urokinase plasminogen activator and method of optimizing therapeutic efficacy App 20030211095 - Higazi, Abd. Al-Roof	2003-11-13
Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots App 20030152563 - Muzykantov, Vladimir R. ; et al.	2003-08-14
Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots Grant 6,488,927 - Muzykantov , et al. December 3, 2	2002-12-03
Compositions and methods for modulating muscle cell and tissue contractility App 20020131964 - Cines, Douglas B. ; et al.	2002-09-19
Compositions And Methods For Prevention And Treatment Of Uncontrolled Formation Of Intravascular Fibrin Clots App 20020099000 - MUZYKANTOV, VLADIMIR R. ; et al.	2002-07-25
Use of lipid conjugates in the treatment of disease App 20020049183 - Yedgar, Saul ; et al.	2002-04-25
suPAR stimulating activity of tcuPA-mediated fibrinolysis and different uses thereof App 20020022025 - Higazi, Abd. Al-Roof	2002-02-21
Use of cross-linked, covalently bound urokinase plasminogen activator (scuPAR)-urokinase plasminogen activator receptor (suPAR) complex as a fibrinolytic agent App 20010046495 - Higazi, Abd. Al-Roof	2001-11-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.